Cite
HARVARD Citation
Okada, M. et al. (2013). THU0248 Patient-Oriented Decision of Early Treatment of Rheumatoid Arthritis with Combination of Triple Conventional Disease Modifying Anti-Rheumatic Drugs or Tumor Necrosis Factor Inhibitors and Methotrexate (Prospective, Open-Label Clinical Trial). Annals of the rheumatic diseases. p. A249. [Online].